Invezz is an independent platform with the goal of helping users achieve financial freedom. In order to fund our work, we partner with advertisers who compensate us for users that Invezz refers to their services. While our reviews and assessments of each product on the site are independent and unbiased, brands may pay to appear higher up our table rankings or place ads in specific areas of the site. The order in which products and services appear on Invezz does not represent an endorsement from us, and please be aware that there may be other platforms available to you than the products and services that appear on our website. Read more about how we make money >
GlaxoSmithKline plc (ETR:GS7)
|Dividend Rate (ttm)||0.8000|
|Trading Day||Sep 15|
|Day's Range||16.52 - 17.5|
|52 Week Range||13.9 - 18.2|
GlaxoSmithKline plc dividends
GlaxoSmithKline plc has a market cap or net worth of €83.12 billion. The enterprise value is €0.
GlaxoSmithKline plc has 5.03 billion shares outstanding.
The trailing PE ratio is 0.0000 and the forward PE ratio is 0.0000. GlaxoSmithKline plc's PEG ratio is 0.0000.
Stock Price Statistics
The stock price has increased by 0.0802%. The beta is 0.0000, so GlaxoSmithKline plc's price volatility has been lower than the market average.
In the last 12 months, GlaxoSmithKline plc had revenue of €0 and earned €0 in profits. Earnings per share was €.
GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET).
The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis.
The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities.
The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom..